System, Test, Carbohydrate Antigen (Ca19-9), For Monitoring And Management Of Pancreatic Cancer
FDA product code NIG · Class 2 · 11 devices · 322 reports · 5 devices named in recalls
- ADVIA Centaur® CA 19-9™ 10491244Siemens Healthcare Diagnostics Inc. · SYSTEM, TEST, CARBOHYDRATE ANTIGEN (CA19-9), FOR MONITORING AND MANAGEMENT OF PANCREATIC CANCER1 recall87 reports
- Atellica IM CA 19-9 10995489Siemens Healthcare Diagnostics Inc. · SYSTEM, TEST, CARBOHYDRATE ANTIGEN (CA19-9), FOR MONITORING AND MANAGEMENT OF PANCREATIC CANCER1 recall73 reports
- Atellica IM CA 19-9 10995490Siemens Healthcare Diagnostics Inc. · SYSTEM, TEST, CARBOHYDRATE ANTIGEN (CA19-9), FOR MONITORING AND MANAGEMENT OF PANCREATIC CANCER1 recall48 reports
- ADVIA Centaur® CA 19-9™ 10491379Siemens Healthcare Diagnostics Inc. · SYSTEM, TEST, CARBOHYDRATE ANTIGEN (CA19-9), FOR MONITORING AND MANAGEMENT OF PANCREATIC CANCER1 recall37 reports
- Atellica IM CA 19-9 11206239Siemens Healthcare Diagnostics Inc. · SYSTEM, TEST, CARBOHYDRATE ANTIGEN (CA19-9), FOR MONITORING AND MANAGEMENT OF PANCREATIC CANCER1 recall0 reports
- Elecsys CA 199 Immunoassay 11776193122Roche Diagnostics GmbH · SYSTEM, TEST, CARBOHYDRATE ANTIGEN (CA19-9), FOR MONITORING AND MANAGEMENT OF PANCREATIC CANCER32 reports
- Elecsys CA 19-9 07027028190Roche Diagnostics GmbH · SYSTEM, TEST, CARBOHYDRATE ANTIGEN (CA19-9), FOR MONITORING AND MANAGEMENT OF PANCREATIC CANCER32 reports
- Dimension Vista® Flex® reagent cartridge CA19-9 10464358Siemens Healthcare Diagnostics Inc. · SYSTEM, TEST, CARBOHYDRATE ANTIGEN (CA19-9), FOR MONITORING AND MANAGEMENT OF PANCREATIC CANCER6 reports
- Alinity 08P3221Abbott GmbH · SYSTEM, TEST, CARBOHYDRATE ANTIGEN (CA19-9), FOR MONITORING AND MANAGEMENT OF PANCREATIC CANCER4 reports
- Access GI Monitor 387687Beckman Coulter, Inc. · System, Test, Carbohydrate Antigen (Ca19-9), For Monitoring And Management Of Pancreatic Cancer2 reports
- ST AIA-PACK PROG II N/ATosoh Corporation · System, Test, Carbohydrate Antigen (Ca19-9), For Monitoring And Management Of Pancreatic Cancer1 report